Your Transparency Vendor Looks Great in a Demo. But Can It Survive a Reporting Deadline?

Table of content

• 1. Where does your HCP data actually come from?
• 2. How does the platform handle regulatory differences between countries?
• 3. How quickly do regulatory changes become system changes?s
• 4. What happens between data collection and final submission?
• 5. What happens when something goes wrong?
• The five questions that should change your vendor evaluation

Author

Umer Tanweer leads the Global Compliance & Analytics function at Vector Health Compliance. His expertise includes multi-country transparency reporting, cross-border value transfer disclosure, and the remediation of compliance systems and processes. At Vector Health, he oversees the design and deployment of advanced analytics frameworks for compliance monitoring, working across regulatory, data science, and operational teams to ensure integrity, scalability, and global alignment.

Vector Health Compliance
Your Leading Partner in Global Sunshine Compliance

Table of content

• 1. Where does your HCP data actually come from?
• 2. How does the platform handle regulatory differences between countries?
• 3. How quickly do regulatory changes become system changes?s
• 4. What happens between data collection and final submission?
• 5. What happens when something goes wrong?
• The five questions that should change your vendor evaluation

A polished dashboard is easy to demonstrate. A compliant submission is much harder.

That distinction is becoming increasingly important for life sciences compliance teams evaluating global HCP transparency and compliance platforms. The real question is no longer simply, “Does this vendor have the functionality we need?”

It is: “Can this platform give us confidence when the data is incomplete, regulations change, systems fail, and a reporting deadline is approaching?”

That is the point at which many vendor evaluations become much more revealing.

Compliance technology is moving beyond isolated reporting tools. Deloitte has noted that life sciences compliance organizations have historically depended heavily on manual processes and multiple data sources, while digital technologies can help automate data collection, monitoring and reporting and shift compliance teams toward more analytical, risk-focused work.

At the same time, the regulatory environment itself continues to evolve. In Italy, for example, Law No. 62/2022 established the framework for the public Sanità Trasparente register, while the Ministry of Health’s testing phase has been launched to verify the platform’s functionality before its full implementation.

So when your organization evaluates a global transparency vendor, the platform demo should be only the beginning of the conversation. Here are five questions that can expose what sits underneath it.

1. Where does your HCP data actually come from?

Every transparency reporting process ultimately depends on accurate HCP and HCO identification. That sounds obvious. Yet this is where a surprising amount of compliance risk originates. An HCP may appear differently across your CRM, expense system, contracting platform and finance system. A name may be entered differently. An institution may have changed its legal name. A professional identifier may be missing. A country-specific identifier may be formatted incorrectly. By the time the reporting team sees the problem, it may already be embedded in thousands of transactions.

Italy provides a useful illustration. As companies prepare for the Sanità Trasparente framework, Law No. 62/2022 requires reporting data to include specific identification details for the relevant recipients and organisations, including tax code or VAT number, making the quality and completeness of underlying HCP and HCO data particularly important. The Ministry of Health describes the register as a system intended to provide public transparency around financial transactions and relationships between companies and healthcare-sector stakeholders.

So don’t ask a vendor merely whether it has an “HCP database.”

Ask: What is the source of the data? How is it validated? How frequently is it refreshed? Which countries are covered? How are duplicates resolved? And what happens when an HCP record cannot be confidently matched?

That last question matters most. A strong vendor should be able to explain not just how it finds good data, but how it manages bad data.

2. How does the platform handle regulatory differences between countries?

“Global compliance” can be a misleading phrase. The world does not have one transparency reporting model. There are national statutory regimes, industry codes, professional requirements, different reporting thresholds, different recipient definitions and different publication mechanisms. Even where countries follow broadly similar transparency principles, the operational requirements can differ significantly.

EFPIA’s own framework illustrates the point. Its 2025 Code includes disclosure requirements and standardized disclosure guidance, while explicitly recognizing the need to operate in accordance with applicable national laws and regulations. The latest guidance also establishes standardized publication expectations to be implemented no later than the 2027 disclosure of 2026 data. That means a vendor should not be able to answer “yes” to global coverage simply because its software can generate an Excel file.

Ask the vendor to demonstrate one transaction across multiple jurisdictions. What changes? What remains consistent? Which rules are configurable? Which rules are hard-coded? And who determines when a regulatory change requires a change in the system? A genuinely global platform should make the complexity visible rather than hide it behind the word “global.”

3. How quickly do regulatory changes become system changes?

This is one of the most important questions in the entire procurement process. Regulatory change is not theoretical. EFPIA continues to update its Code and supporting materials, while national requirements evolve independently. In Italy, the implementation journey for Sanità Trasparente itself demonstrates why compliance teams cannot assume that legislation published in 2022 will translate into an unchanged operational environment years later.

So ask the vendor: “Show us the last regulatory change you incorporated into the platform.” Don’t accept “our regulatory team monitors changes.”

Ask what actually happened. Who identified the change? Who interpreted it? Who determined the system impact? How was the configuration changed? Was client testing required? How were existing workflows affected? And how was the change communicated?

The difference between a vendor that knows regulations and one that can operationalize regulatory change is enormous.

4. What happens between data collection and final submission?

This is where a vendor’s true compliance architecture becomes visible. A reporting platforam should not be evaluated only on the final output.

Ask to see the journey:

• → Source system
• → data integration
• → HCP/HCO matching
• → validation
• → enrichment
• → business-rule checks
• → exception management
• → review
• → approval
• → reporting file
• → submission
• → audit trail.

Where can compliance intervene? Can users see why a record failed? Can they trace a reported value back to the underlying transaction? Can corrections be documented? Can the system distinguish between a genuine compliance exception and a data-quality issue? Can your team reproduce what happened months later?

Deloitte’s research into pharma compliance technology found that many compliance activities have historically involved manual extraction from multiple systems, while more mature digital approaches can automate data collection and allow compliance teams to focus more on risk analysis and targeted monitoring.

That is an important distinction when selecting a vendor. You are not buying a report generator. You are buying the controls around the report.

5. What happens when something goes wrong?

This may be the most important question of all. Every vendor can demonstrate a successful submission. Ask them about the unsuccessful one. What happens when an HCP cannot be matched? What happens when a source system sends incomplete data? What happens when a reporting file fails validation? What happens when your compliance team discovers an error days before a deadline? And what happens when a regulatory requirement changes after your implementation?

The answers tell you whether you are buying software or entering into an operational partnership.

A good vendor should be able to explain escalation paths, ownership, remediation processes, audit trails and support arrangements without resorting to vague promises about “customer success.” Because compliance teams don’t need a partner only when everything works. They need one when it doesn’t.

The five questions that should change your vendor evaluation

The strongest transparency technology evaluations therefore go beyond functionality and price.

They examine:

• the quality and provenance of the underlying HCP/HCO data;
• the platform’s ability to accommodate country-specific requirements;
• the vendor’s process for monitoring and implementing regulatory change;
• the controls surrounding the reporting lifecycle; and
• the support model when something inevitably goes wrong.

The broader lesson is simple.

A transparency platform should not merely produce a report. It should make the path to that report more controlled, traceable and defensible.

That is particularly important as transparency requirements become more sophisticated and companies operate across an increasingly fragmented regulatory landscape.

Before signing a multi-year contract, don’t ask only what the platform can do in a demo.

Ask what it can do when the data is messy, the rules have changed, and the deadline is tomorrow.

Ready to look beyond the demo?

If your organization is evaluating ways to strengthen global transparency reporting, explore how Vector Health Compliance approaches data integration, HCP/HCO master data, validation, audit readiness and compliance-focused analytics through Global Transparency Reporting (GTR).

Explore the solution and see what a more connected transparency reporting process can look like.